 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Pandion Therapeutics Inc. (PAND)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-07-17 Purchase | 2020-07-21 7:28 pm | Pandion Therapeutics Inc. | PAND | Larson Eric D VP | 600 | $18 | $10,800 | 22,125 (Direct) | View |
| 2020-07-17 Purchase | 2020-07-21 7:29 pm | Pandion Therapeutics Inc. | PAND | Frail Donald Director | 10,000 | $18 | $180,000 | 61,113 (Direct) | View |
| 2020-07-17 Purchase | 2020-07-21 7:32 pm | Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks | 1,200 | $18 | $21,600 | 1,200 (Indirect Direct) | View |
| 2020-07-17 Purchase | 2020-07-21 7:33 pm | Pandion Therapeutics Inc. | PAND | Stagliano Nancy Director | 1,000 | $18 | $18,000 | 1,000 (Indirect Direct) | View |
| 2020-07-17 Purchase | 2020-07-21 7:33 pm | Pandion Therapeutics Inc. | PAND | Sundy John Chief Medical Officer | 2,000 | $18 | $36,000 | 115,826 (Direct) | View |
| 2020-07-17 Purchase | 2020-07-21 7:35 pm | Pandion Therapeutics Inc. | PAND | Kakkar Rahul CEO | 14,000 | $18 | $252,000 | 14,000 (Indirect Direct) | View |
| 2020-07-17 Purchase | 2020-07-21 7:39 pm | Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks | 1,450 | $18 | $26,100 | 87,764 (Direct) | View |
| 2020-07-17 Purchase | 2020-07-21 7:39 pm | Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner | 723,222 | $18 | $13,017,996 | 1,000 (Indirect Direct) | View |
| 2020-07-17 Purchase | 2020-07-21 7:44 pm | Pandion Therapeutics Inc. | PAND | Fuglesang Christopher Director 10% Owner | 722,222 | $18 | $12,999,996 | 2,600,773 (Indirect Direct) | View |
| 2020-07-17 Purchase | 2020-07-21 7:44 pm | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 50,111 | $18 | $901,998 | 84,158 (Indirect Direct) | View |
| 2020-07-17 Purchase | 2020-07-21 7:47 pm | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 361,111 | $18 | $6,499,998 | 2,248,304 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-21 7:49 pm | Pandion Therapeutics Inc. | PAND | Boxer Capital LLC Boxer Asset Management Inc. Braslyn Ltd. LEWIS JOSEPH Davis Aaron I. MVA Investors LLC 10% Owner | 722,222 | $18 | $12,999,996 | 2,107,513 (Indirect Direct) | View |
| 2020-07-21 Purchase | 2020-07-21 7:51 pm | Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner | 36,111 | $18 | $649,998 | 110,621 (Indirect) | View |
| 2020-07-17 Purchase | 2020-07-22 4:18 pm | Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner | 361,111 | $18 | $6,499,998 | 2,248,304 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-22 4:30 pm | Pandion Therapeutics Inc. | PAND | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 361,111 | $18 | $6,499,998 | 1,770,023 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-23 4:49 pm | Pandion Therapeutics Inc. | PAND | Mutz Mitchell Director 10% Owner | 46,111 | $18 | $829,998 | 10,000 (Indirect) | View |
| 2020-07-21 Purchase | 2020-07-23 4:50 pm | Pandion Therapeutics Inc. | PAND | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner | 36,111 | $18 | $649,998 | 3,086,084 (Indirect) | View |
| 2020-11-17 Purchase | 2020-11-19 8:15 pm | Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director | 29,394 | $15.29 | $449,400 | 2,630,167 (Indirect) | View |
| 2020-11-19 Purchase | 2020-11-23 5:30 pm | Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director | 197,716 | $15.12 | $2,989,466 | 2,827,883 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-07-17 Conversion | 2020-07-21 7:28 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Freedman Edward D. COO | 2,348 | $0 | 0 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:28 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Freedman Edward D. COO | 2,112 | $18 | 0 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:28 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Freedman Edward D. COO | 53,131 | $18 | 0 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:28 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Freedman Edward D. COO | 660 | $18 | 0 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:28 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Freedman Edward D. COO | 11,974 | $0 | 0 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:28 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Larson Eric D VP | 27,500 | $18 | 22,125 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:29 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Frail Donald Director | 11,741 | $0 | 61,113 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:29 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Frail Donald Director | 4,750 | $18 | 61,113 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:29 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Frail Donald Director | 13,997 | $18 | 61,113 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:29 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Frail Donald Director | 59,872 | $0 | 61,113 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:32 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks | 21,133 | $0 | 1,200 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:32 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks | 56,637 | $18 | 1,200 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:32 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks | 58,239 | $18 | 1,200 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:32 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks | 107,768 | $0 | 1,200 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:33 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Stagliano Nancy Director | 15,004 | $0 | 1,000 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-21 7:33 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Stagliano Nancy Director | 3,674 | $18 | 1,000 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:33 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Stagliano Nancy Director | 13,997 | $18 | 1,000 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:33 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Stagliano Nancy Director | 28,620 | $0 | 1,000 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:33 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Stagliano Nancy Director | 47,898 | $0 | 1,000 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-21 7:33 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Sundy John Chief Medical Officer | 145,420 | $18 | 115,826 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:35 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Kakkar Rahul CEO | 21,133 | $0 | 14,000 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-21 7:35 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Kakkar Rahul CEO | 27,181 | $18 | 14,000 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:35 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Kakkar Rahul CEO | 221,067 | $18 | 14,000 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:35 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Kakkar Rahul CEO | 100,493 | $18 | 14,000 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:35 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Kakkar Rahul CEO | 107,768 | $0 | 14,000 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-21 7:37 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Carlo Rizzuto Director | 13,997 | $18 | 13,997 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:39 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks | 7,044 | $0 | 87,764 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:39 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks | 3,806 | $18 | 87,764 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:39 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks | 13,935 | $18 | 87,764 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:39 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks | 10,486 | $18 | 87,764 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:39 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks | 35,922 | $0 | 87,764 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:39 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner | 1,878,551 | $0 | 1,000 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-21 7:39 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner | 13,997 | $18 | 1,000 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:39 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner | 9,579,462 | $0 | 1,000 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:41 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 3,176,507 | $0 | 0 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:41 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 577,544 | $0 | 0 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:41 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 14,452,795 | $0 | 0 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:41 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,745,458 | $0 | 0 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:41 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 1,245,330 | $0 | 0 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:41 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 333,333 | $0 | 0 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Fuglesang Christopher Director 10% Owner | 1,408,913 | $0 | 2,600,773 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-21 7:44 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Fuglesang Christopher Director 10% Owner | 13,997 | $18 | 2,600,773 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Fuglesang Christopher Director 10% Owner | 7,184,596 | $0 | 2,600,773 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 2,783,892 | $0 | 84,158 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 272,046 | $0 | 84,158 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 99,637 | $0 | 84,158 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 9,736 | $0 | 84,158 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 21,133 | $0 | 84,158 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 7:44 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 13,997 | $18 | 84,158 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 14,196,152 | $0 | 84,158 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 508,090 | $0 | 84,158 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 1,387,268 | $0 | 84,158 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 49,652 | $0 | 84,158 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:44 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner | 107,768 | $0 | 84,158 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:45 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | JDRF T1D Fund LLC 10% Owner | 204,313 | $0 | 0 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:45 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | JDRF T1D Fund LLC 10% Owner | 222,020 | $0 | 0 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:45 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | JDRF T1D Fund LLC 10% Owner | 948,225 | $0 | 0 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:45 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | JDRF T1D Fund LLC 10% Owner | 1,132,170 | $0 | 0 (Direct) | View |
| 2020-07-17 Conversion | 2020-07-21 7:47 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 1,538,724 | $0 | 2,248,304 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:47 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 348,469 | $0 | 2,248,304 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:47 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 7,846,554 | $0 | 2,248,304 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-21 7:47 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 1,776,980 | $0 | 2,248,304 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-21 7:47 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner | 13,997 | $18 | 2,248,304 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:49 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Boxer Capital LLC Boxer Asset Management Inc. Braslyn Ltd. LEWIS JOSEPH Davis Aaron I. MVA Investors LLC 10% Owner | 1,385,291 | $0 | 2,107,513 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:49 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Boxer Capital LLC Boxer Asset Management Inc. Braslyn Ltd. LEWIS JOSEPH Davis Aaron I. MVA Investors LLC 10% Owner | 23,622 | $0 | 2,107,513 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:49 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Boxer Capital LLC Boxer Asset Management Inc. Braslyn Ltd. LEWIS JOSEPH Davis Aaron I. MVA Investors LLC 10% Owner | 7,064,136 | $0 | 2,107,513 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:49 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Boxer Capital LLC Boxer Asset Management Inc. Braslyn Ltd. LEWIS JOSEPH Davis Aaron I. MVA Investors LLC 10% Owner | 120,460 | $0 | 2,107,513 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-21 7:49 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Mutz Mitchell Director 10% Owner | 13,997 | $18 | 13,997 (Direct) | View |
| 2020-07-21 Conversion | 2020-07-21 7:51 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner | 2,783,892 | $0 | 110,621 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:51 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner | 272,046 | $0 | 110,621 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:51 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner | 99,637 | $0 | 110,621 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:51 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner | 9,736 | $0 | 110,621 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:51 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner | 14,196,152 | $0 | 110,621 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:51 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner | 508,090 | $0 | 110,621 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:51 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner | 1,387,268 | $0 | 110,621 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-21 7:51 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner | 49,652 | $0 | 110,621 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-22 4:18 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner | 1,538,724 | $0 | 2,248,304 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-22 4:18 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner | 348,469 | $0 | 2,248,304 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-22 4:18 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner | 7,846,554 | $0 | 2,248,304 (Indirect) | View |
| 2020-07-17 Conversion | 2020-07-22 4:18 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner | 1,776,980 | $0 | 2,248,304 (Indirect) | View |
| 2020-07-17 Option Award | 2020-07-22 4:18 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner | 13,997 | $18 | 2,248,304 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-22 4:30 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 1,408,912 | $0 | 1,770,023 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-22 4:30 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 7,184,596 | $0 | 1,770,023 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-23 4:49 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Mutz Mitchell Director 10% Owner | 3,049,973 | $0 | 10,000 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-23 4:49 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Mutz Mitchell Director 10% Owner | 13,138,905 | $0 | 10,000 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-23 4:49 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Mutz Mitchell Director 10% Owner | 2,414,098 | $0 | 10,000 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-23 4:50 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner | 3,049,973 | $0 | 3,086,084 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-23 4:50 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner | 13,138,905 | $0 | 3,086,084 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-23 4:50 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner | 2,414,098 | $0 | 3,086,084 (Indirect) | View |
| 2020-12-02 Option Award | 2020-12-04 8:04 pm | N/A 2030-12-01 | Pandion Therapeutics Inc. | PAND | Dorton Katina Director | 27,994 | $16.96 | 27,994 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:40 pm | N/A 2031-02-07 | Pandion Therapeutics Inc. | PAND | Sundy John Chief Medical Officer | 73,789 | $17.75 | 73,789 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:41 pm | N/A 2031-02-07 | Pandion Therapeutics Inc. | PAND | Larson Eric D VP | 23,000 | $17.75 | 23,000 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:41 pm | N/A 2031-02-07 | Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks | 73,789 | $17.75 | 73,789 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:45 pm | N/A 2031-02-07 | Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks | 73,789 | $17.75 | 73,789 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:46 pm | N/A 2031-02-07 | Pandion Therapeutics Inc. | PAND | Freedman Edward D. COO | 36,895 | $17.75 | 36,895 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:47 pm | N/A 2031-02-07 | Pandion Therapeutics Inc. | PAND | Kakkar Rahul CEO | 221,367 | $17.75 | 221,367 (Direct) | View |